The stock of RadNet Inc. (NASDAQ:RDNT) is a huge mover today! About 318,128 shares traded hands or 145.80% up from the average. RadNet Inc. (NASDAQ:RDNT) has risen 32.53% since April 13, 2016 and is uptrending. It has outperformed by 28.60% the S&P500.
The move comes after 7 months negative chart setup for the $288.64M company. It was reported on Nov, 15 by Barchart.com. We have $5.52 PT which if reached, will make NASDAQ:RDNT worth $37.52M less.
RadNet Inc. (NASDAQ:RDNT) Ratings Coverage
Out of 3 analysts covering RadNet (NASDAQ:RDNT), 1 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 33% are positive. RadNet has been the topic of 3 analyst reports since March 15, 2016 according to StockzIntelligence Inc. Sidoti initiated it with “Buy” rating and $9 target price in Friday, April 15 report. The firm earned “Hold” rating on Tuesday, March 15 by Jefferies. The firm has “Neutral” rating by Sterne Agee CRT given on Thursday, June 2.
According to Zacks Investment Research, “RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.”
More recent RadNet Inc. (NASDAQ:RDNT) news were published by: Marketwatch.com which released: “Plus the latest data from Realtor.com on 21 home markets across the US” on November 16, 2010. Also Prnewswire.com published the news titled: “RadNet, Inc., a national leader in outpatient diagnostic imaging, selects …” on July 26, 2016. Globenewswire.com‘s news article titled: “RadNet, Inc. Announces the Addition of Lawrence Tanenbaum, M.D. to Its …” with publication date: September 22, 2015 was also an interesting one.
RDNT Company Profile
RadNet, Inc., incorporated on June 19, 2008, is a well-known provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Firm operates directly or indirectly through joint ventures with hospitals, approximately 300 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. The Company’s centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. The Company’s services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Firm operates approximately 140 fixed-site, freestanding outpatient diagnostic imaging facilities in California, over 10 in Delaware, three in Florida, 50 in Maryland, 20 in New Jersey, 20 in the Rochester and Hudson Valley areas of New York, approximately 40 in New York City, as well as five in Rhode Island.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.